Literature DB >> 20663517

Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive: uncontrolled inflammation drives disease progression?

Tianhua Yang1, Dong Zhou, Hermann Stefan.   

Abstract

Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) is a group of chronic disorders characterized by prominent neuronal loss and gliosis in the hippocampus and amygdala. Newly published data indicate that it may be a progressive disease, but the mechanism underlying the progressive nature remains unknown. Recently, substantial evidence for an inflammatory mechanism in MTLE has been documented. We are therefore presenting a review of literature concerning the effects of uncontrolled inflammation on the disease progression of MTLE-HS. We found that increasing amounts of evidence support the association between uncontrolled inflammation and progression of the disease. Uncontrolled inflammatory processes may be a main mechanism underlying the self-propagating cycle of uncontrolled inflammation, blood-brain barrier damage, and seizures that drive the progressive nature. Thus it is important to unravel the principles of communication between the different factors in this cycle. The dynamic modulation of inflammatory processes aimed at preventing or interrupting this cycle has the potential to emerge as a novel therapeutic strategy. This line of therapy might offer new perspectives on the pharmacologic treatment of seizures, and possibly on delaying disease progression or retarding epileptogenesis as well. 2010. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2010        PMID: 20663517     DOI: 10.1016/j.jns.2010.06.002

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  20 in total

1.  Hippocampal "gliosis only" on MR imaging represents a distinct entity in epilepsy patients.

Authors:  Elke Hattingen; Simon Jonas Enkirch; Alina Jurcoane; Maximilian Kruse; Daniel Delev; Alexander Grote; Albert Becker
Journal:  Neuroradiology       Date:  2017-10-30       Impact factor: 2.804

2.  Animal Models of Posttraumatic Seizures and Epilepsy.

Authors:  Alexander V Glushakov; Olena Y Glushakova; Sylvain Doré; Paul R Carney; Ronald L Hayes
Journal:  Methods Mol Biol       Date:  2016

3.  Inhibition of miR-181a-5p reduces astrocyte and microglia activation and oxidative stress by activating SIRT1 in immature rats with epilepsy.

Authors:  Huimin Kong; Huaili Wang; Zhihong Zhuo; Zhenbiao Li; Peichao Tian; Jing Wu; Jian Liu; Zheng Chen; Jiyao Zhang; Qiang Luo
Journal:  Lab Invest       Date:  2020-05-27       Impact factor: 5.662

4.  A case of focal cortical dysplasia type Ib atypically showing reversible intensity changes on magnetic resonance imaging which could be affected by epileptic discharge activity.

Authors:  Naoto Kuroda; Ayataka Fujimoto; Hideo Enoki; Yoshifumi Arai; Tohru Okanishi
Journal:  Childs Nerv Syst       Date:  2019-02-27       Impact factor: 1.475

5.  Cross hippocampal influence in mesial temporal lobe epilepsy measured with high temporal resolution functional magnetic resonance imaging.

Authors:  Victoria L Morgan; Baxter P Rogers; Hasan H Sonmezturk; John C Gore; Bassel Abou-Khalil
Journal:  Epilepsia       Date:  2011-07-29       Impact factor: 5.864

Review 6.  Epilepsy and epileptic syndrome.

Authors:  Tomonori Ono; Aristea S Galanopoulou
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

7.  Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocyte activation, inflammation, and altered expression of channels and receptors.

Authors:  A Das; G C Wallace; C Holmes; M L McDowell; J A Smith; J D Marshall; L Bonilha; J C Edwards; S S Glazier; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2012-06-12       Impact factor: 3.590

Review 8.  Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities.

Authors:  Ping Zheng; Sandy R Shultz; Chris M Hovens; Dennis Velakoulis; Nigel C Jones; Terence J O'Brien
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

Review 9.  Causes of CNS inflammation and potential targets for anticonvulsants.

Authors:  Mercé Falip; Xavier Salas-Puig; Carlos Cara
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

10.  Hippocampus in health and disease: An overview.

Authors:  Kuljeet Singh Anand; Vikas Dhikav
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.